Navigation Links
Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government
Date:3/2/2011

g the Company's financial position, business strategy and other plans and objectives for future operations, and assumptions and predictions about future product demand, supply, manufacturing, costs, marketing and pricing factors are all forward-looking statements. These statements are generally accompanied by words such as "intend," anticipate," "believe," "estimate," "potential(ly)," "continue," "forecast," "predict," "plan," "may," "will," "could," "would," "should," "expect" or the negative of such terms or other comparable terminology. The Company believes that the assumptions and expectations reflected in such forward-looking statements are reasonable, based on information available to it on the date hereof, but the Company cannot provide assurances that these assumptions and expectations will prove to have been correct or that the Company will take any action that the Company may presently be planning. However, these forward-looking statements are inherently subject to known and unknown risks and uncertainties. Actual results or experience may differ materially from those expected or anticipated in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, regulatory policies, available cash, research results, competition from other similar businesses, and market and general economic factors. This discussion should be read in conjunction with the condensed consolidated financial statements and notes thereto included on SEC Form 10-Q for the quarter ending September 30, 2010.Media contact:John S. Kovach, MDPresident & CEOLixte Biotechnology Holdings, Inc.248 Route 25A No. 2East Setauket, NY 11733Tel. 631-942-7959Fax 631-982-5050
'/>"/>
SOURCE Lixte Biotechnology Holdings
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100.
2. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
3. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
4. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
5. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
6. Pharma ChemOutsourcing Targets BioNJ, PA Bio, MassBio, BayBio, SoCalBio, and NY Biotechnology Association Member Companies for September 2011 Show in New Jersey
7. Reportlinker Adds Global Biotechnology Instrumentation Industry
8. NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition
9. Reportlinker Adds Global Agricultural Biotechnology Industry
10. Champions Biotechnology Awarded $1.46 million in Grants
11. Goodwin Biotechnology Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , Chine, 3 juillet 2015 BGI a ... haut débit de l,ADN situé à ... de  l,American College of Pathologists  (Collège des pathologistes ... Hong Kong constituent le ... à recevoir la certification du CAP en Chine, ...
(Date:7/2/2015)... VANCOUVER , July 2, 2015 /PRNewswire/ - ESSA ... that its common shares have been approved for listing and ... "EPIX". ESSA will begin trading on NASDAQ on ... the TSX Venture Exchange under the symbol "EPI". ... on the NASDAQ, each of the Company,s outstanding special warrants ...
(Date:7/2/2015)... , July 2, 2015  New product launches ... its leading role in educating thought leaders about new ... can heavily influence how well a new therapy performs ... study from research and consulting leader Best Practices, LLC, ... need to focus on are early stage thought leader ...
Breaking Medicine Technology:BGI obtient la certification du Collège des pathologistes américains (CAP) 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2
... 2011 Pharmasset, Inc. (Nasdaq: VRUS ), ... and commercializing novel drugs to treat viral infections, today ... ended December 31, 2010. Financial ... 31, 2010 compared to $0.3 million for the quarter ...
... 7, 2011 BD (Becton, Dickinson and Company) (NYSE: ... company, announced today that it signed a definitive agreement ... company that develops and manufactures personal flow cytometers for ... is expected to close during the third quarter of ...
Cached Medicine Technology:Pharmasset Reports Fiscal First Quarter 2011 Financial Results 2Pharmasset Reports Fiscal First Quarter 2011 Financial Results 3Pharmasset Reports Fiscal First Quarter 2011 Financial Results 4Pharmasset Reports Fiscal First Quarter 2011 Financial Results 5Pharmasset Reports Fiscal First Quarter 2011 Financial Results 6BD Announces Agreement to Acquire Accuri Cytometers, Inc. 2BD Announces Agreement to Acquire Accuri Cytometers, Inc. 3
(Date:7/3/2015)... , ... July 03, 2015 ... ... the sessions and speaker lineup for its 2015 Annual Conference , ... August 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... providers, has been retained to lead a national president recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Smoothies are ... is a good blender and easily accessible, quality ingredients. Aurora Natural is proud to ... for an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is ...
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency ... named Mariah N. Manzanares, MD as the new Medical Director of its Frisco facility. ... director of our Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:7/3/2015)... ... ... Every year, One-to-1 Fitness and the Red Deer Fit Body ... community with free fitness training and indoor fitness boot camp classes for 24 straight ... thousands of charity dollars and ended with a $10,000 donation to the Jumpstart organization. ...
Breaking Medicine News(10 mins):Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3
... 10 Winners of the 2007,Award for Excellence in Human ... and Founder of the Health Improvement,Institute., Winners were: ... Online Clinical Trials Principal Investigator Self ... to educate the University,s researchers on the mechanisms by ...
... ALEXANDRIA, Va., Dec. 10 Sen. Max Baucus,(D-Mont.), ... directly,with House leadership on a must-pass Medicare bill ... in his committee last week,but with Congress, scheduled ... Rep. Charles Rangel (D-N.Y.), chair of the House ...
... lymphoma patients with a milder chemotherapy regimen before they ... resulted in long-term complete remission for 45 of 47 ... of Texas M. D. Anderson Cancer Center report at ... Hematology. , The two patients who had relapsed ...
... - Living longer with obesity can lead to both ... hospital, according to two new studies from Purdue University. ... that cite the problems of obesity," said Ken Ferraro, ... which people become obese continues to get younger, we ...
... new treatments, researchers say , , MONDAY, Dec. 10 (HealthDay ... the cancer-susceptibility gene called BRCA1 can cause some breast ... to 20 percent of all breast cancers. BBCs generally ... are almost always associated with hereditary mutations in the ...
... Clinic researchers today presented results of a phase ... first step therapy designed to reduce cancer cells ... showing an improved response over the traditional lenalidomide-dexamethasone ... B. Reeder, M.D., at the American Society of ...
Cached Medicine News:Health News:2007 Human Research Protection Award Recipients Announced 2Health News:NCPA Statement Urging Congress to Include Pharmacy Provisions in Medicare-Medicaid Legislation 2Health News:Gentler chemotherapy before stem cell transplant causes long-term remission of follicular lymphoma 2Health News:Living longer with obesity means heavier burden for hospitals 2Health News:Living longer with obesity means heavier burden for hospitals 3Health News:Mutated Suppressor Gene Leads to a Type of Breast Cancer 2Health News:Mutated Suppressor Gene Leads to a Type of Breast Cancer 3
... A to Z Drug Facts produced ... information on thousands of medications. It ... side effect, drug interactions, patient information ... drug reference for physicians, students, residents, ...
... of current natural product information ... with A to Z Drug ... checking. Includes free updates for ... ideal drug reference for physicians, ...
Instant access to drug-drug and drug-food interaction between thousands of brand and generic drugs plus A to Z Drug Facts monographs. Includes free updates for one year....
... Interaction Principles is the number one polypharmacy ... An understanding of drug interactions has become ... publication of the first edition of this ... - coupled with prolonged human life spans ...
Medicine Products: